Royal London Asset Management Ltd. Buys 1,045 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Royal London Asset Management Ltd. boosted its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 3.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,774 shares of the medical instruments supplier’s stock after purchasing an additional 1,045 shares during the quarter. Royal London Asset Management Ltd. owned about 0.16% of Mettler-Toledo International worth $41,329,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the stock. State Street Corp boosted its position in Mettler-Toledo International by 1.0% during the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after purchasing an additional 9,009 shares in the last quarter. Geode Capital Management LLC boosted its position in Mettler-Toledo International by 0.8% during the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after purchasing an additional 4,166 shares in the last quarter. Principal Financial Group Inc. boosted its position in Mettler-Toledo International by 13.9% during the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after purchasing an additional 33,456 shares in the last quarter. Barclays PLC boosted its position in Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after purchasing an additional 19,609 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after acquiring an additional 28,478 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on MTD shares. Evercore ISI raised their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. Citigroup lowered their price target on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a report on Tuesday, March 4th. Wolfe Research started coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating for the company. Robert W. Baird raised their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Finally, Wells Fargo & Company raised their price target on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $1,380.50.

Insider Activity at Mettler-Toledo International

In related news, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the transaction, the insider now directly owns 734 shares in the company, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Stock Down 1.6 %

Shares of NYSE:MTD opened at $1,200.33 on Friday. Mettler-Toledo International Inc. has a 52-week low of $1,142.91 and a 52-week high of $1,546.93. The stock has a market cap of $25.11 billion, a price-to-earnings ratio of 29.62, a PEG ratio of 3.30 and a beta of 1.15. The business has a 50-day moving average price of $1,293.03 and a 200-day moving average price of $1,312.51.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, equities analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.